... industry have been rewarded with sky-high valuations. IMS Health Holdings won't be one. IMS, a 60-year-old Danbury company that sells data on prescription use to drugmakers and analysts, is asking investors to buy shares in its initial public ...
via Danbury Newswire http://ift.tt/1fDFdv1
via Danbury Newswire http://ift.tt/1fDFdv1
No comments:
Post a Comment